Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Relapsing Remitting Hispanic Multiple Sclerosis Forms

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by University of Southern California.
Recruitment status was  Recruiting
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Lilyana Amezcua, University of Southern California Identifier:
First received: May 1, 2012
Last updated: June 29, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)